Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway

Circulation Research
Kasem NithipatikomGarrett J Gross

Abstract

Cytochrome P450s (CYP) and their arachidonic acid (AA) metabolites have important roles in regulating vascular tone, but their function and specific pathways involved in modulating myocardial ischemia-reperfusion injury have not been clearly established. Thus, we characterized the effects of several selective CYPomega-hydroxylase inhibitors and a CYPomega-hydroxylase metabolite of AA, 20-hydroxyeicosatetraenoic acid (20-HETE), on the extent of ischemia-reperfusion injury in canine hearts. During 60 minutes of ischemia and particularly after 3 hours of reperfusion, 20-HETE was produced at high concentrations. A nonspecific CYP inhibitor, miconazole, and 2 specific CYPomega-hydroxylase inhibitors, 17-octadecanoic acid (17-ODYA) and N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS), markedly inhibited 20-HETE production during ischemia-reperfusion and produced a profound reduction in myocardial infarct size (expressed as a percent of the area at risk) (19.6+/-1.7% [control], 8.4+/-2.5% [0.96 mg/kg miconazole], 5.9+/-2.2% [0.28 mg/kg 17-ODYA], and 10.8+/-1.8% [0.40 mg/kg DDMS], P<0.05, respectively). Conversely, exogenous 20-HETE administration significantly increased infarct size (26.9+/-1.9%, P<0.05). Several CYPomega-hydroxy...Continue Reading

References

May 18, 1999·The American Journal of Physiology·L RudasD L Eckberg
Aug 30, 2000·Prostaglandins & Other Lipid Mediators·J H Capdevila, J R Falck
Feb 13, 2001·Biochemical and Biophysical Research Communications·J BylundE H Oliw
Jan 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·David J GranvilleRoberta A Gottlieb

❮ Previous
Next ❯

Citations

Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jun-Yan LiuBruce D Hammock
Aug 25, 2010·The Journal of Biological Chemistry·Cosima ArnoldWolf-Hagen Schunck
Dec 17, 2008·Cardiovascular Research·Christopher M JenkinsRichard W Gross
Nov 15, 2011·Current Opinion in Nephrology and Hypertension·Kevin R Regner, Richard J Roman
May 9, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cheng FangXinxin Ding
Aug 3, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Qinghua ZengChengwen Sun
Jan 17, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Marija RenicRichard J Roman
Dec 17, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Chengqun HuangRoberta A Gottlieb
Jan 4, 2008·American Journal of Physiology. Renal Physiology·Vani NilakantanFrank Park
Jul 19, 2006·Canadian Journal of Physiology and Pharmacology·Manreet K Chehal, David J Granville
Nov 1, 2005·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Noriyuki Miyata, Richard J Roman
Apr 23, 2013·Drug Metabolism Reviews·Abdulaziz M S AlsaadAyman O S El-Kadi
Nov 28, 2013·Expert Opinion on Drug Metabolism & Toxicology·Andrew Rowland, Arduino A Mangoni
Dec 16, 2010·Kidney International·Richard J RomanKevin R Regner
Dec 5, 2008·Kidney International·Kevin R RegnerRichard J Roman
May 7, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Meijuan XuPing Li
Dec 2, 2004·Journal of Molecular and Cellular Cardiology·Eric R GrossGarrett J Gross
Jun 12, 2016·Prostaglandins & Other Lipid Mediators·Maayan WaldmanEdith Hochhauser
Feb 14, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Zhenyan FuNaoyuki Sato
Mar 5, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Kasem Nithipatikom, Garrett J Gross
Oct 14, 2006·Circulation Research·Rodolphe FischmeisterGrégoire Vandecasteele
Sep 30, 2009·IUBMB Life·Ketul R ChaudharyJohn M Seubert
Oct 11, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Kasem NithipatikomGarrett J Gross
Feb 14, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Kasem NithipatikomGarrett J Gross
Apr 11, 2006·American Journal of Physiology. Heart and Circulatory Physiology·David J Granville, Roberta A Gottlieb
Apr 11, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Elizabeth A HausnerXi Yang
Jul 6, 2014·Fundamental & Clinical Pharmacology·Caroline BarauDidier Morin
Nov 22, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingxing DiaoXiaoyan Chen
Aug 3, 2017·Journal of Cardiovascular Pharmacology·Shan JiangChengwen Sun
Jul 16, 2010·Pharmacological Reports : PR·Cosima ArnoldWolf-Hagen Schunck

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.